A scanning dynamic collimator for spot-scanning proton minibeam production.

Sci Rep

Institut Curie, Université PSL, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400, Orsay, France.

Published: September 2021

In proton minibeam radiation therapy, proton minibeams are typically produced by modulating a uniform field using a multislit collimator. Multislit collimators produce minibeams of fixed length and width, and a new collimator has to be manufactured each time a new minibeam array is required, limiting its flexibility. In this work, we propose a scanning dynamic collimator for the generation of proton minibeams arrays. The new collimator system proposed is able to produce any minibeam required on an on-line basis by modulating the pencil beam spots of modern proton therapy machines, rather than a uniform field. The new collimator is evaluated through Monte Carlo simulations and the produced proton minibeams are compared with that of a multislit collimator. Furthermore, a proof of concept experiment is conducted to demonstrate the feasibility of producing a minibeam array by repositioning (i.e. scanning) a collimator. It is concluded that besides the technical challenges, the new collimator design is producing equivalent minibeam arrays to the multislit collimator, whilst is flexible to produce any minibeam array desired.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443660PMC
http://dx.doi.org/10.1038/s41598-021-97941-wDOI Listing

Publication Analysis

Top Keywords

proton minibeams
12
multislit collimator
12
minibeam array
12
collimator
10
scanning dynamic
8
dynamic collimator
8
proton minibeam
8
uniform field
8
produce minibeam
8
minibeam
7

Similar Publications

Proton minibeam radiation therapy (pMBRT) dose profile is characterized by highly heterogeneous dose in the plane perpendicular to the beam direction and rapidly changing depth dose profiles. Typically, dose measurements are benchmarked against in-house Monte Carlo simulation tools. It is essential to have a treatment planning system (TPS) that can accurately predict pMBRT doses in tissue and be available via commercial platform for preclinical and clinical use.

View Article and Find Full Text PDF
Article Synopsis
  • Proton Minibeam Radiation Therapy has been promising in enhancing treatment efficacy compared to traditional radiation, but more research into its biological mechanisms is needed.
  • A mechanical collimation setup was developed to produce 250µm minibeams with a 1000µm spacing, with optimization using Monte Carlo simulations conducted at various proton therapy sites.
  • Results showed a peak-to-valley dose ratio (PVDR) of 10 in Dresden and 14 in Seattle, with some discrepancies between dosimetry methods that can be addressed with correction factors.
View Article and Find Full Text PDF

Challenges for the Implementation of Primary Standard Dosimetry in Proton Minibeam Radiation Therapy.

Cancers (Basel)

November 2024

Radiotherapy and Radiation Dosimetry, National Physical Laboratory, Teddington TW11 0LW, UK.

Article Synopsis
  • Spatial fractionation of proton fields in cancer treatment improves sparing of healthy tissue while ensuring tumor control.
  • This study demonstrated the use of the National Physical Laboratory's Primary Standard Proton Calorimeter to measure absorbed dose in a proton beam with a specific configuration.
  • Results indicated that uncertainty in absorbed dose measurements was mainly due to positioning accuracy, suggesting that reference dosimetry should focus on measuring Dose-Area Product or using SOBP for more reliable outcomes in spatially fractionated fields.
View Article and Find Full Text PDF

Background: The clinical translation of proton minibeam radiation therapy (pMBRT) presents significant challenges, particularly in developing an optimal treatment planning technique. A uniform target dose is crucial for maximizing anti-tumor efficacy and facilitating the clinical acceptance of pMBRT. However, achieving a high peak-to-valley dose ratio (PVDR) in organs-at-risk (OAR) is essential for sparing normal tissue.

View Article and Find Full Text PDF

Background: Ultra-high dose rate (UHDR/FLASH) irradiations, along with particle minibeam therapy (PMBT) are both emerging as promising alternatives to current radiotherapy techniques thanks to their improved healthy tissue sparing and similar tumor control.

Purpose: Monte Carlo (MC) modeling of a commercial machine delivering 5-7 MeV electrons at UHDR. This model was used afterward to compare measurements against simulations for an experimental setup combining both FLASH and PMBT modalities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!